Welcome to our dedicated page for BlackRock Duration SEC filings (Ticker: BLW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on BlackRock Duration's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into BlackRock Duration's regulatory disclosures and financial reporting.
BlackRock Limited Duration Income Trust director reported a new grant of cash-settled incentive units linked to the trust’s common shares. On 01/02/2026, the insider acquired 674.49 Performance Rights at a derivative price of $13.71 per right. Each Performance Right is tied to the cash value of one share of BlackRock Limited Duration Income Trust and was accrued under the BlackRock Deferred Compensation Plan.
The Performance Rights will be settled 100% in cash at the deferral period chosen by the reporting person, rather than in actual fund shares. After this transaction, the director beneficially owns 14,577.18 Performance Rights, all held in direct form.
BlackRock Limited Duration Income Trust reported that one of its directors acquired new deferred compensation awards tied to the trust’s common shares. On 01/02/2026, the director received 634.82 Performance Rights under the BlackRock Deferred Compensation Plan. Each Performance Right is convertible into the cash value of one share of BlackRock Limited Duration Income Trust and will be settled 100% in cash at a deferral period chosen by the director.
Following this transaction, the director beneficially owned 13,942.71 derivative securities directly, with the filing showing a price of $13.71 per Performance Right. These awards are structured as cash-settled, share-value–linked compensation rather than direct share ownership.
BlackRock Limited Duration Income Trust reported a director-level compensation change involving deferred performance rights linked to its common shares. On 01/02/2026, the director acquired 861.06 performance rights at a derivative price of $13.71 each. Each performance right represents the cash value of one share of BlackRock Limited Duration Income Trust and will be settled 100% in cash at a deferral period chosen by the director. After this transaction, the director beneficially owned 8,280.62 performance rights on a direct basis.
BlackRock Limited Duration Income Trust reported a routine director compensation change. On 01/02/2026, a director of the trust accrued 626.88 Performance Rights under the BlackRock Deferred Compensation Plan at a reference price of $13.71 per right. Each Performance Right represents the cash value of one share of BlackRock Limited Duration Income Trust common stock, but will be settled entirely in cash at a future deferral date chosen by the director rather than in actual shares. Following this accrual, the director beneficially owns 13,654.08 derivative securities linked to the trust’s common stock, reflecting deferred, cash-settled compensation rather than an immediate stock purchase or sale.
A director of BlackRock Limited Duration Income Trust reported a new deferred compensation award tied to the trust’s common shares. On 01/02/2026, the director acquired 86.03 Performance Rights at a reference price of $13.71 per right under the BlackRock Deferred Compensation Plan. Each Performance Right represents the cash value of one share of BlackRock Limited Duration Income Trust and is designed to be settled 100% in cash at a future deferral date chosen by the director.
BlackRock Limited Duration Income Trust reported a director’s deferred compensation award using derivative securities. On 01/02/2026, the director acquired 888.75 Performance Rights, each tied to the cash value of one share of BlackRock Limited Duration Income Trust at a reference price of $13.71. After this transaction, the director beneficially owned 68,845.19 derivative securities on a direct basis.
The Performance Rights were accrued under the BlackRock Deferred Compensation Plan. Each right is convertible into the cash value of one common share and is to be settled 100% in cash at a deferral period chosen by the director, meaning no shares of the trust are delivered when they settle.
BlackRock Limited Duration Income Trust director reported acquiring additional cash-settled Performance Rights linked to the trust’s common shares under the BlackRock Deferred Compensation Plan. On 01/02/2026, the reporting person acquired 19.54 Performance Rights at a reference price of
BlackRock Limited Duration Income Trust (BLW) director reported a Form 4 transaction on 10/01/2025 involving Performance Rights under the BlackRock Deferred Compensation Plan. The transaction is coded “A” with a Price of Derivative Security of
Arthur Philip Steinmetz, a director of BlackRock Limited Duration Income Trust (BLW), reported a transaction dated 10/01/2025 on Form 4 showing the acquisition of 841.33 Performance Rights under the BlackRock Deferred Compensation Plan. The filing states each Performance Right is convertible into the cash value of one share of BLW and that the Performance Rights "are to be settled 100% in cash" at the deferral election chosen by the reporting person.
The table in the filing lists a price of $14 and shows 7,240.69 shares (or share-equivalents) beneficially owned by the reporting person following the reported transaction. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person on 10/03/2025.